Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Completed NCT02856594

Minimizing ICU Neurological Dysfunction With Dexmedetomidine-induced Sleep

Conditions: Postoperative Delirium, Sleep, Anesthesia

Sex: All
Ages: 60 Years – N/A
Healthy volunteers: Yes
Phase: PHASE2, PHASE3
Enrollment: 469
Sponsor: Massachusetts General Hospital

Location: Massachusetts General Hospital Boston Massachusetts

Summary

This study aims to determine whether, compared with placebo, the nighttime administration of a intravenous dexmedetomidine is effective at inducing sleep and preventing postoperative delirium in extubated post-cardiac surgical patients.

Eligibility Criteria

Inclusion Criteria: * Age ≥ 60 * Scheduled for a cardiac surgical procedure with planned post-operative admission to the CSICU for ≥ 24 hours * Scheduled same day surgical admission Exclusion Criteria: * Blind, deafness or the inability to speak English * Greater than 2 days of ICU admission in the month preceding the current surgical procedure * Renal and liver failure requiring dialysis or Child-Pugh score \> 5 * Follow-up difficulties (i.e. active substance abuse, psychotic disorder, homelessness) * Previous cardiac surgery within 1 year of surgical procedure * Allergy to dexmedetomidine * Chronic therapy with benzodiazepines and/or antipsychotics * Severe deficit due to structural or anoxic brain damage * Surgical procedure requiring total circulatory arrest Objective Drop Criteria * Scheduled for a second surgical procedure during hospital stay * Post-operative intubation \> 12 hours

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT02856594). StuddyBuddy aggregates publicly available trial information.